NCT03834818 Collecting Outcomes and Managing Pain After Surgery
| NCT ID | NCT03834818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000 participants in total. It began in 2025-01-13 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this study is to measure pain and psychosocial patient reported outcomes, objective functionality, and actual daily at home opioid usage in orthopedic patients. The study's goal following the data collection is to predict which patients are at high risk for chronic opioid use.
Eligibility Criteria
Inclusion Criteria: * aged 18-90 years old who are undergoing elective orthopedic surgery at Duke Health. * Patients must have their own smartphone IOS or Android device. * Patients must be able to read English. Exclusion Criteria: * Lacking capacity to provide consent. * Cannot read English * Under 18 years of age * Older than 90 years of age
Contact & Investigator
Michael Bullock, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT03834818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03834818 currently recruiting?
Yes, NCT03834818 is actively recruiting participants. Contact the research team at ashley.burke@duke.edu for enrollment information.
Where is the NCT03834818 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT03834818 clinical trial?
NCT03834818 is sponsored by Duke University. The principal investigator is Michael Bullock, MD at Duke University. The trial plans to enroll 10,000 participants.